GlobeNewswire Inc | Jan 7, 2021 08:13AM EST

January 07, 2021

RICHLAND, Wash., Jan. 07, 2021 (GLOBE NEWSWIRE) -- Isoray, Inc. (NYSE American: ISR), a medical technology company and seed brachytherapy innovator powering expanding treatment options throughout the body, today announced that Chief Executive Officer Lori Woods will present at the H.C. Wainwright BioConnect 2021 Conference. The virtual conference will be held January 11-14, 2021.

The on-demand presentation will be available on Isorays Investor Relations section of the Companys website at https://isoray.com/investors/presentations/ at 6:00 a.m. EDT on Monday, January 11, 2021. It will remain available on the website for 90 days.

About IsorayIsoray, Inc., through its subsidiary, Isoray Medical, Inc. is the sole producer of Cesium-131 brachytherapy seeds, which are expanding brachytherapy options throughout the body. Learn more about this innovative Richland, Washington company and explore the many benefits and uses of Cesium-131 by visiting www.isoray.com. Follow us onLinkedIn and Twitter. Join us on Facebook.

Contact:Investor Relations: Mark Levin (501) 255-1910Media and Public Relations: Sharon Schultz (302) 539-3747